Filter
1029
Text search:
therapeutic
agents
Featured
Recommendations
131
New Publications
265
Language
Document type
No document type
514
Guidelines
225
Studies & Reports
173
Manuals
58
Strategic & Response Plan
20
Training Material
14
Fact sheets
11
Situation Updates
8
Brochures
2
Resource Platforms
2
Infographics
1
Online Courses
1
Countries / Regions
India
76
South Africa
41
Kenya
34
Global
34
Ethiopia
27
Uganda
22
Nigeria
20
Zambia
17
Tanzania
16
Latin America and the Carribbean
16
Bangladesh
14
Sierra Leone
13
Liberia
13
Nepal
13
Ghana
12
Rwanda
12
Western and Central Europe
11
Myanmar / Burma
10
Philippines
8
Congo, Democratic Republic of
7
Namibia
7
Africa
7
Cambodia
6
Lesotho
6
Russia
6
Burkina Faso
5
USA
5
Zimbabwe
5
Guinea
4
Thailand
4
Indonesia
4
Malawi
4
Mozambique
4
Brazil
4
Ukraine
4
Senegal
3
Mali
3
Cameroon
3
Haiti
3
Germany
3
Syria
3
Eswatini/ Swaziland
3
North Macedonia
3
Spain
3
South Sudan
2
Iraq
2
Afghanistan
2
Sudan
2
Benin
2
Botswana
2
Yemen
2
Middle East and North Africa
2
South–East Asia Region
2
Asia
2
Fiji
2
Bhutan
2
Venezuela
2
Tajikistan
2
Georgia
2
Vietnam
2
Gabon
2
Somalia
1
Pakistan
1
Jordan
1
Turkey
1
China
1
Malaysia
1
Singapore
1
Peru
1
Serbia
1
Colombia
1
Libya
1
Angola
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Paraguay
1
Solomon Islands
1
Eastern Europe
1
Albania
1
Armenia
1
Laos
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
North America
1
Denmark
1
France
1
Maldives
1
Mauritius
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
393
Clinical Guidelines
149
Public Health
47
Women & Child Health
42
Key Resources
34
Pharmacy & Technologies
17
Capacity Building
12
Toolboxes
AMR
150
Mental Health
75
Pharmacy
69
HIV
65
TB
52
COVID-19
43
NTDs
41
Ebola & Marburg
34
NCDs
33
Caregiver
30
Rapid Response
17
Malaria
13
Disability
10
Refugee
10
Planetary Health
9
Conflict
8
Natural Hazards
6
Specific Hazards
5
2.0 Rapid Response
5
Cholera
3
Global Health Education
3
Social Ethics
3
Polio
2
Zika
2
Health Financing Toolbox
1
Interim policy guidance
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte
...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher
...
The prevalence, availability, and use of antimalarial medicines (AMLs) were studied in six Cambodian provinces along the Thai-Cambodian border. The study was divided into two parts: the first looked at the quality of AMLs available in Pursat, Pailin, Battambang, Bantey Meanchey, Oddar Meanchey, and
...
Guidelines on Management of COVID-19 in Kenya
recommended
It has been over a year since Kenya identified the first case of COVID-19 in the country. The Government formed the National COVID-19 task force, which supported the country's response through multi-sectoral technical working groups on testing, case management, risk communication and community engag
...
EACS produces Guidelines for the management of people living with HIV in Europe. The English version is regularly updated by the guidelines panels with major revision every other year and minor revisions in the years in between. Guidelines are published in the autumn and translated into additional l
...
Antimicrobial resistance (AMR) has emerged as a major public health problem all over the world. Infections caused by resistant microbes fail to respond to treatment, resulting in prolonged illness and greater risk of death. This document focuses on the mechanism to develop a practically applicable h
...
Buruli ulcer (BU) is a bacterial skin infection that is caused by Mycobacterium ulcerans and mainly affects people who reside in the rural areas of Africa and in suburban and beach resort communities in Australia.
Antimicrobial resistance (AMR) is a multifaceted, international public health problem, which poses a direct threat to the safety of the population of South Africa. A national response is required to complement the development of a global plan, as articulated in the WHO’s draft resolution EB134/37
...
Snakebite envenoming constitutes a serious medical condition that primarily affects residents of rural communities in Africa, Asia, Latin America, and New Guinea. It is an occupational, environmental, and domestic health hazard that exacerbates the already impoverished state of these communities. Co
...
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to
...
The International Rescue Committee (IRC) is a leading humanitarian agency dedicated to helping people whose lives have been shattered by conflict and disaster to survive, recover, and gain control of their future. Health comprises nearly half of IRC’s program portfolio globally and encompasses thr
...
Ethiopian Medicines Formulary
recommended
2nd edition
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS functions in the country, what actors are involved in this
...
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant
tuberculosis (XDR-TB) increasingly occur in resource-constrained settings.
In the context of a national response to MDR- and XDR-TB, health workers in
TB clinics (in district hospitals and some accredited health centres) wil
...
